Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Impression Healthcare Limited

INVESTOR PRESENTATION - Impression Healthcare Limited

ASX:IHL

Impression Healthcare Limited

Health

Impression Healthcare Limited is an innovative healthcare company that sells customised oral devices both direct-to-the- consumer and via the Company’s growing B2B preferred practitioner network of dentists. With its own laboratory in Victoria, Australia, Impression offers best-in-class teeth-protection and helps its customers to combat bruxism, snoring, mild-to-moderate sleep apnoea and teeth discolouration with custom-fitted oral devices. Impression has broadened its commitment to disruption in the healthcare sector by progressing multiple opportunities in the field of medicinal cannabis. IHL has its licenses in place to import, export and distribute cannabis products. In March of 2019, Impression executed a binding collaboration with Cannvalate to undertake four medicinal cannabis clinical trials. Cannvalate is Australia’s largest distributor of medicinal cannabis products.

Read more

Market Cap

$176.82m

Price at Close

$0.17

4w avg. Volume

2.29m

4w avg. Turnover

$359.39k

Announcements
announcementt+2 movementdate
  • Cleansing Notice and Appendix 2A

    Issued Capital

  • 0.00%

    04 Jan 2021

0.00%

04 Jan 2021
  • Cleansing Notice and Appendix 2A

    Issued Capital

  • -3.23%

    31 Dec 2020

-3.23%

31 Dec 2020
  • Cleansing Notice and Appendix 2A

    Issued Capital

  • +6.67%

    24 Dec 2020

+6.67%

24 Dec 2020
  • First patients recruited for IHL-42X (OSA) trial

    Progress Report · Market sensitive

  • +6.90%

    20 Dec 2020

+6.90%

20 Dec 2020
  • Director's interest - Appendix 3Y

    Shareholder Details

  • -6.45%

    17 Dec 2020

-6.45%

17 Dec 2020
  • Cleansing Notice & Appendix 2A

    Issued Capital

  • -6.45%

    17 Dec 2020

-6.45%

17 Dec 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • -9.38%

    16 Dec 2020

-9.38%

16 Dec 2020
  • Positive results from IHL-216A TBI/concussion study

    Progress Report · Market sensitive

  • -5.88%

    14 Dec 2020

-5.88%

14 Dec 2020
  • IHL initiates psilocybin clinical trial for anxiety disorder

    Stock Exchange Announcement · Market sensitive

  • +13.79%

    07 Dec 2020

+13.79%

07 Dec 2020
  • Appendix 3Y

    Shareholder Details

  • +20.69%

    04 Dec 2020

+20.69%

04 Dec 2020
Market Data

Current Price

$0.17

52WK HIGH

$0.195

52WK LOW

$0.029

1YR RETURN

+153.73%

1YR RETURN VS. SECTOR

+116.22%

90 DAY RETURN

+82.80%

ASX RANK

663

/2,047

SECTOR RANK

58

/168

SHARES OUTSTANDING

1.04b
ASX:IHL

Impression Healthcare Limited

Health

Impression Healthcare Limited is an innovative healthcare company that sells customised oral devices both direct-to-the- consumer and via the Company’s growing B2B preferred practitioner network of dentists. With its own laboratory in Victoria, Australia, Impression offers best-in-class teeth-protection and helps its customers to combat bruxism, snoring, mild-to-moderate sleep apnoea and teeth discolouration with custom-fitted oral devices. Impression has broadened its commitment to disruption in the healthcare sector by progressing multiple opportunities in the field of medicinal cannabis. IHL has its licenses in place to import, export and distribute cannabis products. In March of 2019, Impression executed a binding collaboration with Cannvalate to undertake four medicinal cannabis clinical trials. Cannvalate is Australia’s largest distributor of medicinal cannabis products.

Read more

Market Cap

$176.82m

Price at Close

$0.17

4w avg. Volume

2.29m

4w avg. Turnover

$359.39k

ASX:IHL is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.